<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WF2GR6S" height="0" width="0" style="display:none;visibility:hidden">

Livestream: The Life-long Care of Individuals with Lennox-Gastaut Syndrome: Strategies for Outcomes Optimization from Childhood Through Adulthood


Lennox-Gastaut syndrome (LGS) remains a challenging condition to understand, diagnose, and manage. Neuroscience/neurology clinicians, including nurses and nurse practitioners (NPs), encounter significant challenges in the management of patients with LGS, due to the severe symptoms and morbidities, diagnostic delays, and therapeutic barriers involved with the condition. Patients with LGS need interdisciplinary collaborative care that includes optimal and long-term management plans to minimize disease burden and maximize quality of life (QoL) over the lifespan.

In this CME Outfitters livestream symposium, expert faculty will discuss the disease burden and impact of LGS on QoL for patients and caregivers, the utilization of diagnostic criteria and distinguishing features of both early- and late-onset LGS to achieve early and accurate diagnosis, and strategies to optimize LGS management across the lifespan of these patients.

Register here:

CMEO Webcast

Live Webcast: Monday, March 17th, 2025 at 10:00 am PT / 1:00 pm ET
This activity offers CME credit for:

Jointly Accredited Provider
Physicians (ACCME) 1.0
Nurses (ANCC) 1.0
Physician Assistants (AAPA): 1.0
ABIM MOC 1.0
MIPS Improvement Activity
Royal College MOC

Credit Expiration Date: 3/17/2025

By entering your mobile phone number you agree that CME Outfitters can send you periodic text messages about CME/CE activities. This free service is FCC CAN-SPAM compliant. You may update message preferences or unsubscribe at any time. Check your wireless provider for any message and data rates that may apply.

 

Expert Faculty

_FacultyMM146-03
Elaine Wirrell, MD
Moderator
Professor and Chair
Child and Adolescent Neurology
Mayo Clinic
Rochester, MN
_FacultyMM146-01
Tracy Dixon-Salazar, PhD
Patient Advocate
Executive Director
Lennox-Gastaut Syndrome (LGS) Foundation
San Diego, CA
_FacultyMM146-01 (1)
Bethany Thomas, DNP
Epilepsy Nurse Practitioner
Hospital of the University of Pennsylvania
Philadelphia, PA

 

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Evaluate the disease burden and impact of LGS on QoL for both patients and caregivers
  • Utilize diagnostic criteria and distinguishing features of both early- and late-onset LGS to achieve early and accurate diagnosis in all patients
  • Develop strategies to optimize management of LGS across patients’ lifespans

Financial Support

This program is supported by an independent medical education grant from Jazz Pharmaceuticals

Target Audience

 

Neuroscience nurse practitioners (NPs) and nurses 

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nurses (ANCC) 1.0

This activity is designated for 1.00 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

 

Disclosure Declaration

Dr. Wirrell reports the following financial relationships:

Advisory Board: Jazz Pharmaceuticals, Inc. and Longboard Pharmaceuticals

Consultant: Data Safety and Monitoring Boards (DSMB): Acadia Pharmaceuticals Inc.; Amicus Therapeutics, Inc.; Encoded Therapeutics, Inc.; GRIN Therapeutics; Longboard Pharmaceuticals; and Neurocrine Biosciences, Inc.

Research Support: Takeda Pharmaceutical Company Limited/Ovid Therapeutics Inc. (Site Principal investigator for OVID935 in DEEs)

Dr. Dixon-Salazar reports no financial relationships to disclose.

Dr. Thomas reports the following financial relationships:

Advisory Board: Jazz Pharmaceuticals, Inc.; Neurelis, Inc.; and SK Life Science, Inc.

Consultant: Jazz Pharmaceuticals, Inc. and SK Life Science, Inc.

Speakers Bureau: Jazz Pharmaceuticals, Inc.; Neurelis, Inc.; and SK Life Science, Inc.

The following individuals have no financial relationships to disclose: 

Thai Nguyen, MD, MHA (Peer Reviewer)
Shirley Michelle Franks, MSN, APRN, FNP-BC (Peer Reviewer)
Susan Perry (Planning Committee)
Chelsey Goins, PhD (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

 

Questions about this activity?